Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
Abstract Tumor-infiltrating lymphocyte (TIL) therapy is a type of adoptive cellular therapy by harvesting infiltrated lymphocytes from tumors, culturing and amplifying them in vitro and then infusing back to treat patients. Its diverse TCR clonality, superior tumor-homing ability, and low off-target...
Main Authors: | Shuhang Wang, Jingwei Sun, Kun Chen, Peiwen Ma, Qi Lei, Shujun Xing, Zhongzheng Cao, Shujun Sun, Zicheng Yu, Yarong Liu, Ning Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12916-021-02006-4 |
Similar Items
-
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
by: Yueshui Zhao, et al.
Published: (2022-08-01) -
Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
by: Mohammad Hossein Kazemi, et al.
Published: (2022-10-01) -
ACT Up TIL Now: The Evolution of Tumor-Infiltrating Lymphocytes in Adoptive Cell Therapy for the Treatment of Solid Tumors
by: Thomas Morgan Hulen, et al.
Published: (2021-07-01) -
Progress on Tumor Infiltrating Lymphocytes in Immunotherapy and Prognosis Evaluation of Breast Cancer
by: HONG Chenchen, et al.
Published: (2022-11-01) -
Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors?
by: Biaoru Li
Published: (2022-10-01)